Afatinib in patients with EGFR mutation-positive (EGFRm plus ) NSCLC harbouring uncommon mutations: Experience in xxxReal-Worldxxx clinical practice

A Maerten
, W Brueckl
, E Laack
, C Hoffmann
, CC Zhou
, YL Wu

Department of Internal Medicine III, Division of Respiratory Medicine, Allergology and Sleep Medicine

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	160-160
Journal	ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
Volume	14
Publication status	Published - 2018

Keywords

LUNG-CANCER

Cite this

@article{26525a1e0bd143709d8d4f330734fbaa,

title = "Afatinib in patients with EGFR mutation-positive (EGFRm plus ) NSCLC harbouring uncommon mutations: Experience in xxxReal-Worldxxx clinical practice",

keywords = "LUNG-CANCER",

author = "A Maerten and W Brueckl and E Laack and C Hoffmann and CC Zhou and YL Wu",

year = "2018",

language = "English",

volume = "14",

pages = "160--160",

journal = "ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY",

issn = "1743-7555",

}

TY - JOUR

T1 - Afatinib in patients with EGFR mutation-positive (EGFRm plus ) NSCLC harbouring uncommon mutations: Experience in xxxReal-Worldxxx clinical practice

AU - Maerten, A

AU - Brueckl, W

AU - Laack, E

AU - Hoffmann, C

AU - Zhou, CC

AU - Wu, YL

PY - 2018

Y1 - 2018

KW - LUNG-CANCER

M3 - Abstract (Journal)

SN - 1743-7555

VL - 14

SP - 160

EP - 160

JO - ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

JF - ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

ER -